Business · 21/07/2011
FDA Releases Guidance for Electrocardiograph Electrodes to Mitigate Health Risks
The FDA has made available a guidance document outlining special controls for electrocardiograph electrodes to address risks of adverse tissue reactions and misdiagnosis, recommending testing and labeling for these devices.
Original source language: Federal Register — Health and Human ServicesOpen original release →